CENTESSA PHARMACEUTICALS-ADR (CNTA) Stock Cash Flow
NASDAQ:CNTA - Nasdaq - US1523091007 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -223.85M | -235.76M | -151.09M | -216.21M | -381.07M | |||
| Depreciation Amortization | 919.00K | 942.00K | 810.00K | 130.00K | 30.00K | |||
| Change In Working Capital | -4.34M | 24.46M | -43.50M | -5.69M | -5.84M | |||
| Interest Paid | 9.24M | 10.09M | 9.91M | 7.28M | 1.48M | |||
| Taxes Paid | 82.00K | 82.00K | 2.94M | 1.30M | N/A | |||
| Other non cash items | 65.25M | 68.30M | 33.44M | 21.22M | 251.76M | |||
| OPERATING CASH FLOW | -162.01M | -142.06M | -160.34M | -200.55M | -135.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -34.00K | -169.00K | -1.14M | -190.00K | |||
| Other Investing Activity | -207.85M | 31.30M | -126.83M | 210.00K | 63.44M | |||
| INVESTING CASH FLOW | -207.88M | 31.27M | -127.00M | -930.00K | 63.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -762.00K | N/A | 0.00 | 73.93M | |||
| Stock Issued/Repurchased | 368.21M | 370.83M | 21.12M | 720.00K | 586.50M | |||
| Other Financing Activity | N/A | -5.32M | 0.00 | -260.00K | -280.00K | |||
| FINANCING CASH FLOW | 357.35M | 364.75M | 21.12M | 460.00K | 660.15M | |||
| Exchange Rate Effect | -509.00K | 1.23M | 615.00K | -420.00K | 1.82M | |||
| CHANGE IN CASH | -13.06M | 255.19M | -265.61M | -201.44M | 590.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -162.01M | -142.06M | -160.34M | -200.55M | -135.11M | |||
| Capital Expenditure | N/A | -34.00K | -169.00K | -1.14M | -190.00K | |||
| FREE CASH FLOW | -162.05M | -142.09M | -160.51M | -201.69M | -135.30M | |||
All data in USD